Markets

Market

News Details

(17/12/2025 16:49)

Lupin receives VAI classification from USFDA for Nagpur injectable facility

Lupin on Wednesday said it has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification from the US Food and Drug Administration (USFDA) for its injectable manufacturing facility in Nagpur.

The EIR was issued following an inspection conducted from September 8 to September 16, 2025. A VAI classification indicates that while certain objectionable conditions were observed, the USFDA does not intend to take or recommend any regulatory or administrative action at this stage.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.